We are live on ! Find out more
CALA

Calithera Biosciences, Inc

Delisted

CALA was delisted on the 1st of February, 2023.

112 hedge funds and large institutions have $204M invested in Calithera Biosciences, Inc in 2017 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 38 increasing their positions, 23 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 15

65% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 23

23% more funds holding

Funds holding: 91112 (+21)

10% less call options, than puts

Call options by funds: $768K | Put options by funds: $855K

50% less capital invested

Capital invested by funds: $406M → $204M (-$202M)

Holders
112
Holders Change
+21
Holders Change %
+23.08%
% of All Funds
2.54%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
36
Increased
38
Reduced
23
Closed
15
Calls
$768K
Puts
$855K
Net Calls
-$87K
Net Calls Change
+$531K
Name Holding Trade Value Shares
Change
Change in
Stake
VFA
51
Virtus Fund Advisers
Connecticut
$348K +$533K +2,083 New
GH
52
GAM Holding
Switzerland
$336K
QCMA
53
Quad Capital Management Advisors
New York
$334K +$512K +2,000 New
AA
54
ALPS Advisors
Colorado
$328K +$503K +1,966 New
QIM
55
Quantitative Investment Management
Virginia
$320K +$492K +1,920 New
Macquarie Group
56
Macquarie Group
Australia
$317K +$428K +1,670 +726%
Tudor Investment Corp
57
Tudor Investment Corp
Connecticut
$295K +$452K +1,765 New
CSS
58
Cubist Systematic Strategies
Connecticut
$280K +$429K +1,675 New
New York State Common Retirement Fund
59
New York State Common Retirement Fund
New York
$273K
CS
60
Credit Suisse
Switzerland
$273K +$16.4K +64 +4%
Two Sigma Investments
61
Two Sigma Investments
New York
$250K +$383K +1,494 New
SCA
62
Secor Capital Advisors
New York
$247K +$378K +1,477 New
RhumbLine Advisers
63
RhumbLine Advisers
Massachusetts
$241K -$73.5K -287 -17%
AllianceBernstein
64
AllianceBernstein
Tennessee
$236K +$73K +285 +25%
ARTA
65
A.R.T. Advisors
New York
$234K +$359K +1,403 New
TRSOTSOK
66
Teachers Retirement System of the State of Kentucky
Kentucky
$230K
Manulife (Manufacturers Life Insurance)
67
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$207K +$11K +43 +4%
Bank of America
68
Bank of America
North Carolina
$201K +$217K +849 +236%
ProShare Advisors
69
ProShare Advisors
Maryland
$198K +$303K +1,183 New
IC
70
Iconiq Capital
California
$194K
State of Wisconsin Investment Board
71
State of Wisconsin Investment Board
Wisconsin
$192K
EMG
72
Ellington Management Group
Connecticut
$191K +$293K +1,145 New
Acadian Asset Management
73
Acadian Asset Management
Massachusetts
$181K +$257K +1,005 +1,272%
AIG
74
American International Group
New York
$172K +$1.28K +5 +0.5%
Lazard Asset Management
75
Lazard Asset Management
New York
$167K +$257K +1,003 New

CALA Hedge Fund Activity: Q4 2017 in Review

112 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q4 2017, worth a combined $204M — down 50% from $406M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new CALA positions and 15 closed out — a net gain of 21 holders — while 38 added to existing stakes and 23 trimmed.

The largest buyer was Millennium Management, adding an estimated $12.3M. The largest seller was Adage Capital Partners, cutting an estimated $24.9M.

  • 112 institutional investors held Calithera Biosciences, Inc (CALA) as of Q4 2017, up from 91 in Q3 2017.
  • Funds reported $204M of Calithera Biosciences, Inc stock for Q4 2017, down 50% quarter-over-quarter.
  • 36 funds opened new Calithera Biosciences, Inc positions in Q4 2017 and 15 closed out, a net change of +21 holders.
  • The largest Calithera Biosciences, Inc buyer in Q4 2017 was Millennium Management, an estimated $12.3M added.
  • The largest Calithera Biosciences, Inc seller in Q4 2017 was Adage Capital Partners, an estimated $24.9M sold.

Based on aggregated 13F filings for Q4 2017.